Biomerica Inc financial data

Symbol
BMRA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
17571 Von Karman Avenue, Irvine, CA
State of incorporation
DE
Fiscal year end
May 31
Latest financial report
10-Q - Q3 2024 - Oct 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 408 % -28.3%
Quick Ratio 101 % -13.8%
Debt-to-equity 34.9 % +23.8%
Return On Equity -84.6 % -21.9%
Return On Assets -62.7 % -15.8%
Operating Margin -118 % -0.11%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.8M shares 0%
Common Stock, Shares, Outstanding 16.8M shares 0%
Entity Public Float 14.5M USD -66%
Common Stock, Value, Issued 1.35M USD 0%
Weighted Average Number of Shares Outstanding, Basic 16.8M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 16.8M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.51M USD +1.74%
Revenue from Contract with Customer, Excluding Assessed Tax 5.51M USD +1.74%
Cost of Revenue 5.02M USD +11.5%
Research and Development Expense 1.32M USD -22.4%
Operating Income (Loss) -6.5M USD -1.85%
Nonoperating Income (Expense) 364K USD +41.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.14M USD -0.18%
Income Tax Expense (Benefit) 23K USD -68.1%
Net Income (Loss) Attributable to Parent -6.16M USD +0.61%
Earnings Per Share, Basic -0.37 USD/shares +9.76%
Earnings Per Share, Diluted -0.37 USD/shares +9.76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.82M USD -64.7%
Accounts Receivable, after Allowance for Credit Loss, Current 1.55M USD +8.46%
Inventory, Net 1.94M USD +3.46%
Assets, Current 6.45M USD -44.3%
Property, Plant and Equipment, Net 184K USD -15.6%
Operating Lease, Right-of-Use Asset 666K USD -30.9%
Intangible Assets, Net (Excluding Goodwill) 207K USD +2.48%
Other Assets, Noncurrent 203K USD +111%
Assets 7.87M USD -40.5%
Accounts Payable, Current 288K USD -16.3%
Employee-related Liabilities, Current 643K USD -3.6%
Accrued Liabilities, Current 850K USD +55.1%
Liabilities, Current 2.15M USD +23.2%
Operating Lease, Liability, Noncurrent 373K USD -47.1%
Liabilities 2.52M USD +2.98%
Accumulated Other Comprehensive Income (Loss), Net of Tax -108K USD -3.85%
Retained Earnings (Accumulated Deficit) -49.5M USD -14.2%
Stockholders' Equity Attributable to Parent 5.35M USD -50.4%
Liabilities and Equity 7.87M USD -40.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.34M USD +19.7%
Net Cash Provided by (Used in) Financing Activities 1.78M USD +121%
Net Cash Provided by (Used in) Investing Activities -63K USD -85.3%
Common Stock, Shares Authorized 25M shares 0%
Common Stock, Shares, Issued 16.8M shares 0%
Common Stock, Par or Stated Value Per Share 0.08 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.35M USD +22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.35M USD -67.1%
Deferred Tax Assets, Valuation Allowance 10.4M USD +16%
Deferred Tax Assets, Gross 10.4M USD +16%
Operating Lease, Liability 707K USD -30.1%
Payments to Acquire Property, Plant, and Equipment 21K USD -38.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.17M USD +0.82%
Lessee, Operating Lease, Liability, to be Paid 753K USD -32.2%
Operating Lease, Liability, Current 334K USD +9.15%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7K USD -98.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 378K USD +2.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 46K USD -54%
Lessee, Operating Lease, Liability, to be Paid, Year Three 101K USD -73.1%
Deferred Tax Assets, Operating Loss Carryforwards 6.66M USD +14.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 4.43M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 101K USD -73.7%
Operating Lease, Payments 90K USD +3.45%
Additional Paid in Capital 53.6M USD +1.41%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 17K USD +21.4%
Depreciation, Depletion and Amortization 76K USD -77.6%
Deferred Tax Assets, Net of Valuation Allowance 8.09M USD
Share-based Payment Arrangement, Expense 77K USD -54.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares